Kura Oncology is trading at $13.69, up +10.40%, after President and CEO Troy Wilson purchased 100,000 shares for approximately $1.24 million on August 24, 2026.
- Shares were acquired at a weighted average price of $12.39 and disclosed through an SEC filing.
- The purchase was reported as the reason for the sharp premarket and intraday rise.
- Biotech sector strength is providing additional support.